Skip to main content
OncoCyte Corporation (OCX)
NASDAQ: OCX · IEX Real-Time Price · USD
2.740
+0.090 (3.40%)
At close: May 31, 2024, 4:00 PM
2.790
+0.050 (1.82%)
After-hours: May 31, 2024, 4:20 PM EDT

OncoCyte Revenue

OncoCyte had revenue of $1.38M in the twelve months ending March 31, 2024, with 57.94% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $176.00K, a -40.74% decrease year-over-year. In the year 2023, OncoCyte had annual revenue of $1.50M with 56.89% growth.

Revenue (ttm)
$1.38M
Revenue Growth
+57.94%
P/S Ratio
26.50
Revenue / Employee
$32,140
Employees
43
Market Cap
36.62M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.50M545.00K56.89%
Dec 31, 2022958.00K-1.24M-56.41%
Dec 31, 20212.20M982.00K80.76%
Dec 31, 20201.22M--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
The Oncology Institute 342.71M
Fortress Biotech 85.11M
Cara Therapeutics 16.94M
Renalytix 2.22M
Cyclo Therapeutics 1.13M
VYNE Therapeutics 423.00K
Revenue Rankings

OCX News

More News